Ezaki Glico Lifts FY2027 Forecast on Margin Expansion and Overseas Growth
Ezaki Glico Co., Ltd. (TSE:2206), Japan’s leading confectionery and nutritional foods manufacturer, reported first-quarter results for fiscal year 2026 (ended December 2025) that significantly exceeded prior-year performance, with net profit surging 46.0% year-over-year despite modest revenue growth. The company’s operating profit more than doubled the pace of revenue expansion, signaling structural cost improvements and operational efficiency gains that management expects to accelerate through the full year.
| Metric | Q1 FY2026 | YoY Change |
|---|---|---|
| Revenue | JPY 85.3bn | +10.3% |
| Operating Profit | JPY 3.70bn | +40.7% |
| Ordinary Income | JPY 4.96bn | +35.5% |
| Net Profit | JPY 3.58bn | +46.0% |
| Operating Margin | 4.3% | — |
| Equity Ratio | 72.0% | +150 bps |
Business Overview
Ezaki Glico Co., Ltd. is a diversified food and confectionery conglomerate with core strength in frozen desserts, chocolate, and snack foods. The company has expanded into dairy products, curry-based meals, and nutritional supplements, positioning itself as a health-focused consumer staples player. International operations, particularly in Asia, have become an increasingly material growth driver.
Q1 Performance: Profit Growth Outpaces Revenue
The quarter’s standout feature is the disproportionate profit expansion relative to top-line growth. Revenue increased 10.3% to JPY 85.3bn, yet operating profit jumped 40.7% to JPY 3.70bn and net profit climbed 46.0% to JPY 3.58bn. This profit-to-revenue ratio divergence reflects two concurrent dynamics: operational leverage from higher sales volume, and disciplined cost management that offset inflationary pressures on raw materials.
The operating margin of 4.3% remains below the company’s historical range, constrained by a 110-basis-point increase in cost of goods sold as a percentage of revenue. However, this headwind was more than offset by efficiency gains in selling, general, and administrative expenses, particularly in sales promotion and personnel cost allocation. The equity ratio strengthened to 72.0% from 70.5%, indicating improved financial stability and reduced reliance on debt financing.
Ordinary income (keijo rieki, a Japan-specific metric encompassing operating profit plus non-operating income such as interest and dividend receipts) rose 35.5% to JPY 4.96bn, suggesting favorable financial income contributions alongside core business performance.
Overseas Expansion Driving Profitability
Segment performance reveals that international operations are the primary profit engine. Overseas business revenue surged 26.9%, with operating profit climbing 46.7%—the strongest growth rate across all segments. This acceleration reflects robust demand in China and other Asian markets, where Ezaki Glico’s confectionery and nutritional product portfolios are gaining traction among middle-class consumers.
Domestically, the dairy segment experienced a modest operating profit decline, attributed to softening demand for legacy products such as frozen novelties. The health and nutrition segment, which includes the company’s strategic investment in plant-based beverages (“Almond Effect”), remained in operating loss at JPY 1.29bn. Management views this as a necessary investment phase to capture the expanding Japanese health-conscious consumer segment, though the timeline for profitability remains unclear.
Next Year Guidance
Management has issued full-year FY2027 guidance reflecting significant profit acceleration:
| Metric | FY2027 Forecast | YoY Change |
|---|---|---|
| Revenue | JPY 380.0bn | +5.1% |
| Operating Profit | JPY 14.0bn | +60.2% |
| Net Profit | JPY 10.0bn | +98.5% |
The guidance implies an operating margin of 3.7% for the full year—a modest contraction from the current trajectory, but the 60.2% operating profit growth substantially outpaces the 5.1% revenue growth, signaling confidence in cost structure optimization and pricing power. The net profit forecast of JPY 10.0bn represents near-doubling versus full-year FY2026 actual results, suggesting material contributions from non-operating income or favorable tax effects beyond core operational improvements. This represents an ambitious but achievable target contingent on sustained overseas momentum and successful margin recovery in domestic segments.
What to Watch
Overseas Sustainability: The 26.9% international revenue growth and 46.7% profit expansion are exceptional. Monitor whether this pace can be sustained amid geopolitical headwinds in Asia and potential currency volatility affecting yen-denominated earnings.
Health Segment Inflection: The health and nutrition business remains unprofitable. Investors should track quarterly progress toward breakeven, particularly for plant-based beverage products, which represent a strategic bet on shifting Japanese consumer preferences.
Domestic Margin Recovery: Domestic segment operating profit has stalled. Watch for evidence that pricing actions or product mix shifts can restore profitability without sacrificing market share in core confectionery categories.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.